Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections” | Zendy

Erica N. Parker | Zendy; Brett N. Cain | Zendy; Behnoush Hajian | Zendy; Rebecca J. Ulrich | Zendy; Emily J. Geddes | Zendy; Sulyman Barkho | Zendy; Hyang Yeon Lee | Zendy; John D. Williams | Zendy; Malik Raynor | Zendy; Diana Caridha | Zendy; Angela Zaino | Zendy; Jason M. Rohde | Zendy; Mark Zak | Zendy; Mrinal Shekhar | Zendy; Kristen A. Muñoz | Zendy; Kara Rzasa | Zendy; Emily R. Temple | Zendy; Diana K. Hunt | Zendy; Xiannu Jin | Zendy; Chau Vuong | Zendy; Kristina Pan | Zendy; Aya M. Kelly | Zendy; Michael P. Mulligan | Zendy; Katie K. Lee | Zendy; Gee W. Lau | Zendy; Deborah T. Hung | Zendy; Paul J. Hergenrother | Zendy

Open Access

Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections”

Author(s) -

Erica N. Parker,

Brett N. Cain,

Behnoush Hajian,

Rebecca J. Ulrich,

Emily J. Geddes,

Sulyman Barkho,

Hyang Yeon Lee,

John D. Williams,

Malik Raynor,

Diana Caridha,

Angela Zaino,

Jason M. Rohde,

Mark Zak,

Mrinal Shekhar,

Kristen A. Muñoz,

Kara Rzasa,

Emily R. Temple,

Diana K. Hunt,

Xiannu Jin,

Chau Vuong,

Kristina Pan,

Aya M. Kelly,

Michael P. Mulligan,

Katie K. Lee,

Gee W. Lau,

Deborah T. Hung,

Paul J. Hergenrother

Publication year - 2022

Publication title -

acs central science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.893

H-Index - 76

eISSN - 2374-7951

pISSN - 2374-7943

DOI - 10.1021/acscentsci.2c00969

Subject(s) - in vivo , antibiotics , gram , drug discovery , microbiology and biotechnology , drug candidate , biology , computational biology , medicine , drug , bioinformatics , pharmacology , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research